1 TWENTYFOURSEVENBIOPHARMA Issue 2 / June 2025 WELCOME ELLIE BRUNI Publishing Director TWENTYFOURSEVENBIOPHARMA Biopharma is an industry where time appears to operate only in extremes. Drug development is a years, if not decades-long process, and regulatory structures are debated and revised extensively before implementation. And yet, each year the pace of new technologies, practices, and innovations entering the market seems like it is only accelerating. This paradox is felt strongest at conferences. The past few months have been spent sprinting from DCAT to CPHI to BIO, giving the gifts of sore feet and (more importantly) the opportunity to interact with hundreds of members of the industry. The individuals have in turn presented 24/7 Biopharma with thousands of ideas about the past, present, and (most importantly) future of the industry. Every year these ideas coalesce around a few key topics. AI integration, patient-centricity, and GLP-1s are some of the most popular at this current inflection point. At times, it can feel like we spend too much time focusing on these select ideas, as if we’re fixated on them. But companies do innovate within these relatively broad buckets, and hardly a day goes by at a conference without encountering a genuinely innovative idea. Over the years, many of these bold ideas have not only taken shape, but seen widespread use and acceptance within the industry at large. And yet, within these gatherings of new and exciting ideas, a focus on partnerships is always present. No company exists in a vacuum, and no business model exists without clients. Consequently, not only is there not a day that passes without the topic coming up, there’s hardly a conversation that happens without it being mentioned at least in passing. The collective focus serves not only as a continual reminder for us to keep our own partners in mind, but also the contradictory nature of biopharma. Because while some things move fast, and others progress glacially, partnership is one of the increasingly few constants. Publishing Director: Ellie Bruni | +44 (0) 7872 516194 ellie.bruni@247biopharma.com Advertising: info@247biopharma.com Editorial contact: Please send your news and suggestions for feature articles to the editorial team at editor@247biopharma.com TWENTYFOURSEVENBIOPHARMA is published by BIBO Publishing SL, Av. Diagonal, 409, 1St Floor, 08008, Barcelona, Spain. Disclaimer: The disclaimer has an error: BIBO Publishing SL will not be held responsible or liable for errors or omissions supplied or contained in this publication, although due care and attention are taken to ensure all content is accurate at the time of going to press. BIBO Publishing SL also will not be held responsible for any false claims made by advertisers, or in articles contributed by external authors. Copyright: The contents of this publication are copyright © BIBO Publishing SL 2024. No part of this publication can be reproduced or transmitted in any form without the express permission of the publisher. ISSN 2516-4481
RkJQdWJsaXNoZXIy MjY2OTA4MA==